01 9Harvoni
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 272
2019 Revenue in Millions : 643
Growth (%) : -58
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 212
2020 Revenue in Millions : 272
Growth (%) : -22
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 114
2021 Revenue in Millions : 212
Growth (%) : -46
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 70
2022 Revenue in Millions : 115
Growth (%) : -39
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2015 Revenue in Millions : 2,127
2014 Revenue in Millions : 13,864
Growth (%) : 552%
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2016 Revenue in Millions : 9,081
2015 Revenue in Millions : 13,864
Growth (%) : -34
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2017 Revenue in Millions : 4,370
2016 Revenue in Millions : 9,081
Growth (%) : -52
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2018 Revenue in Millions : 1,222
2017 Revenue in Millions : 4,370
Growth (%) : -72%
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 643
2018 Revenue in Millions : 1,222
Growth (%) : -47
LOOKING FOR A SUPPLIER?